Name:
s41598-017-02462-0.pdf
Size:
2.289Mb
Format:
PDF
Description:
FInal Published Version
Author
Rutter, Erica M.Stepien, Tracy L.
Anderies, Barrett J.
Plasencia, Jonathan D.
Woolf, Eric C.
Scheck, Adrienne C.
Turner, Gregory H.
Liu, Qingwei
Frakes, David
Kodibagkar, Vikram
Kuang, Yang
Preul, Mark C.
Kostelich, Eric J.
Affiliation
Univ Arizona, Dept MathIssue Date
2017-05-31
Metadata
Show full item recordPublisher
NATURE PUBLISHING GROUPCitation
Mathematical Analysis of Glioma Growth in a Murine Model 2017, 7 (1) Scientific ReportsJournal
Scientific ReportsRights
Copyright © The Author(s) 2017. This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Five immunocompetent C57BL/6-cBrd/cBrd/Cr (albino C57BL/6) mice were injected with GL261-luc2 cells, a cell line sharing characteristics of human glioblastoma multiforme (GBM). The mice were imaged using magnetic resonance (MR) at five separate time points to characterize growth and development of the tumor. After 25 days, the final tumor volumes of the mice varied from 12 mm(3) to 62 mm(3), even though mice were inoculated from the same tumor cell line under carefully controlled conditions. We generated hypotheses to explore large variances in final tumor size and tested them with our simple reaction-diffusion model in both a 3-dimensional (3D) finite difference method and a 2-dimensional (2D) level set method. The parameters obtained from a best-fit procedure, designed to yield simulated tumors as close as possible to the observed ones, vary by an order of magnitude between the three mice analyzed in detail. These differences may reflect morphological and biological variability in tumor growth, as well as errors in the mathematical model, perhaps from an oversimplification of the tumor dynamics or nonidentifiability of parameters. Our results generate parameters that match other experimental in vitro and in vivo measurements. Additionally, we calculate wave speed, which matches with other rat and human measurements.ISSN
2045-2322PubMed ID
28566701Version
Final published versionSponsors
Graduate Assistance of Areas in National Need (GAANN) [P200A120120]; NSF [DMS-1148771]; National Science Foundation [DGE-1311230, 1512553, DMS-1518529, DMS-1615879]; Barrow Neurological Foundation and Arizona State University; Newsome United Kingdom Chair in Neurosurgery ResearchAdditional Links
http://www.nature.com/articles/s41598-017-02462-0ae974a485f413a2113503eed53cd6c53
10.1038/s41598-017-02462-0
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © The Author(s) 2017. This article is licensed under a Creative Commons Attribution 4.0 International License.
Related articles
- Intracranial implantation with subsequent 3D in vivo bioluminescent imaging of murine gliomas.
- Authors: Abdelwahab MG, Sankar T, Preul MC, Scheck AC
- Issue date: 2011 Nov 6
- Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction.
- Authors: Resende FF, Bai X, Del Bel EA, Kirchhoff F, Scheller A, Titze-de-Almeida R
- Issue date: 2016 Feb 8
- Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells.
- Authors: Clark AJ, Safaee M, Oh T, Ivan ME, Parimi V, Hashizume R, Ozawa T, James CD, Bloch O, Parsa AT
- Issue date: 2014 Dec 3
- Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells.
- Authors: Yi L, Zhou C, Wang B, Chen T, Xu M, Xu L, Feng H
- Issue date: 2013 Aug
- Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.
- Authors: Ferrer-Font L, Arias-Ramos N, Lope-Piedrafita S, Julià-Sapé M, Pumarola M, Arús C, Candiota AP
- Issue date: 2017 Sep

